,i  #aaf? ,,congress  #a/ ,session  ,h4 
,r4 #dech  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,septemb] #bf1        
#bjai,mr4 ,wel* 7= himself & ,mr4       
,mc,kinley7 introduc$ ! foll[+ bill2 :i*
 0 ref]r$ to ! ,committee on ,en]gy &   
,comm]ce  ,a ,,bill  ,to am5d title     
,,iii ( ! ,public ,heal? ,s]vice ,act to
 limit ! orphan drug exclusion "u ! drug
 disc\nt program "u section #cdj;,b (   
su* title4  #a4 ,%ort title ,?is ,act   
may be cit$ z ! ,clos+ ,loopholes =     
,orphan ,drugs ,act4  #b4 ,limit+ !     
orphan drug exclusion "u #cdj;,b drug   
disc\nt program  7a7 ,9 g5]al ,section  
#cdj;,b7e7 ( ! ,public ,heal? ,s]vice   
,act 7#db ,u4,s4,c4 #bef;b7e77 is am5d$ 
by ins]t+ be=e ! p]iod at ! end !       
foll[+3 :5 transf]r$1 prescrib$1 sold1  
or o!rwise us$ = ! r>e condition or     
disease = :i* su* drug is s designat$4  
7b7 ,effective date ,! am5dm5t made by  
subsection 7a7 %all apply ) respect to  
cov]$ outpati5t drugs pur*as$ on or aft]
 ! date ( ! enactm5t ( ?is ,act4